Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Fourth COVID vaccine partially effective against Omicron: Israeli study
The yet-to-be peer-reviewed study tested the efficacy and safety of vaccines and analysed whether the combination of vaccines from…
Stempeutics gets DCGI nod for phase-III clinical trial on its product for treating COVID patients
The company will be using its stem cell product, Stempeucel, for conducting the label extension phase-III clinical trial
COVID treatment: Centre issues revised guidelines on use of drugs and therapies
The revised guidelines continue to recommend Emergency Use Authorisation (EUA) or off-label use of Remdesivir in patients with…
Strides Pharma’s Singapore arm gets US FDA nod for generic version of oseltamivir phosphate
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Tamiflu for oral suspension, 6…
Atrimed Pharmaceuticals introduces capsule that can inhibit viral replication
The formulation has been tested against the Delta variant and was found to be effective. AI-based studies prove that it is also…
MSF provides free telemedicine consultation for COVID-19 patients in India
MSF doctors and nurses are available on the toll-free helpline 24 hours a day and seven days a week, and will conduct…
Pharma Budget 2022
Pharma leaders and experts share their concerns about the industry, and expectations from Budget 2022
Ono Pharma expands drug discovery collaboration with Neurimmune AG
The collaboration focusses on creating antibody drugs against new therapeutic targets in the field of neurodegenerative diseases…
US FDA grants priority review to Daiichi Sankyo and AstraZeneca’s sBLA of Enhertu
Enhertu is a HER2-directed Antibody Drug Conjugate (ADC) being jointly developed by Daiichi Sankyo and AstraZeneca for treatment…
Pfizer to boost COVID-19 pill production with French deal
The decision is part of Pfizer's strategy to boost global production of the pill, Paxlovid, which was found to be nearly 90 per…